Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.492NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.492NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.540NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.540NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.487NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.487NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.118NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.118NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.501NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.501NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.226NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.226NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.485NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.485NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.119NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.119NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.276NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.276NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.111NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.111NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.506NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.506NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.6.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.6.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.438.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.438.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.254NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.254NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.1.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.39.1.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.418NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.418NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.9.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.9.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.40NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.122NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.122NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BY.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BY.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.123 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used